Author: Barkoff, Courtney M.; Mousa, Shaker A.
Title: Pharmacotherapy in COVID 19: Potential Impact of Targeting the Complement System Cord-id: f6t0fkez Document date: 2020_12_24
ID: f6t0fkez
Snippet: Coronavirus disease 2019 (COVID-19), a respiratory illness caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has claimed over one million lives worldwide since December 2019. The complement system, while a first-line immune defense against invading pathogens, has off-target effects that lead to increases in inflammation, tissue damage, and thrombosis; these are common, life-threatening complications seen in patients with COVID-19. This review explores the pot
Document: Coronavirus disease 2019 (COVID-19), a respiratory illness caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has claimed over one million lives worldwide since December 2019. The complement system, while a first-line immune defense against invading pathogens, has off-target effects that lead to increases in inflammation, tissue damage, and thrombosis; these are common, life-threatening complications seen in patients with COVID-19. This review explores the potential impact of complement activation in COVID-19 and possible treatments targeting the complement system.
Search related documents:
Co phrase search for related documents- liver injury and low mortality: 1
- liver injury and lung function: 1, 2, 3, 4, 5, 6, 7, 8
- liver injury and lung inflammation: 1, 2, 3, 4, 5
- liver injury and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54
- liver injury and lupus erythematosus: 1, 2
- liver injury and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- liver injury and lymphopenia leukopenia: 1, 2
- lmwh weight heparin and loading dose: 1
- lmwh weight heparin and low molecular lmwh weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- lmwh weight heparin and low mortality: 1, 2, 3, 4
- lmwh weight heparin and lung inflammation: 1, 2
- lmwh weight heparin and lung injury: 1, 2
- lmwh weight heparin and lymphocyte count: 1
- lmwh weight heparin and lymphocyte recovery: 1
- loading dose and low molecular lmwh weight heparin: 1
- loading dose and low mortality: 1
- loading dose and lung function: 1
- loading dose and lymphocyte count: 1, 2
- loading dose and lymphocyte count normalization: 1
Co phrase search for related documents, hyperlinks ordered by date